Water Island Capital’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-84,697
| Closed | -$187K | – | 90 |
|
|
2023
Q2 | $187K | Buy |
84,697
+60,197
| +246% | +$125K | 0.02% | 68 |
|
|
2023
Q1 | $62.2K | Sell |
24,500
-25,010
| -51% | -$49.4K | ﹤0.01% | 74 |
|
|
2022
Q4 | $92.6K | Hold |
49,510
| – | – | 0.01% | 81 |
|
|
2022
Q3 | $127K | Buy |
49,510
+523
| +1% | +$1.3K | 0.01% | 82 |
|
|
2022
Q2 | $95K | Sell |
48,987
-5,881
| -11% | -$12.8K | 0.01% | 79 |
|
|
2022
Q1 | $163K | Sell |
54,868
-1,104
| -2% | -$4.15K | 0.01% | 74 |
|
|
2021
Q4 | $251K | Buy |
55,972
+12,376
| +28% | +$58.7K | 0.01% | 64 |
|
|
2021
Q3 | $212K | Buy |
43,596
+9,750
| +29% | +$53.7K | 0.01% | 58 |
|
|
2021
Q2 | $231K | Buy |
+33,846
| New | +$274K | 0.01% | 59 |
|
|
2021
Q1 | – | Sell |
-78,859
| Closed | -$494K | – | 116 |
|
|
2020
Q4 | $494K | Sell |
78,859
-146,550
| -65% | -$862K | 0.03% | 88 |
|
|
2020
Q3 | $1.22M | Sell |
225,409
-90,644
| -29% | -$449K | 0.1% | 58 |
|
|
2020
Q2 | $1.65M | Sell |
316,053
-35,888
| -10% | -$159K | 0.15% | 30 |
|
|
2020
Q1 | $1.11M | Sell |
351,941
-66,740
| -16% | -$246K | 0.08% | 32 |
|
|
2019
Q4 | $1.69M | Sell |
418,681
-13,043
| -3% | -$45.2K | 0.12% | 40 |
|
|
2019
Q3 | $1.86M | Sell |
431,724
-380,158
| -47% | -$1.52M | 0.12% | 44 |
|
|
2019
Q2 | $3.24M | Buy |
811,882
+445,234
| +121% | +$2.12M | 0.08% | 64 |
|
|
2019
Q1 | $1.97M | Buy |
366,648
+48,130
| +15% | +$311K | 0.1% | 63 |
|
|
2018
Q4 | $1.63M | Sell |
318,518
-121,208
| -28% | -$920K | 0.12% | 61 |
|
|
2018
Q3 | $4.26M | Buy |
439,726
+153,226
| +53% | +$1.55M | 0.23% | 69 |
|
|
2018
Q2 | $2.92M | Buy |
286,500
+30,000
| +12% | +$339K | 0.16% | 74 |
|
|
2018
Q1 | $3.33M | Buy |
256,500
+75,000
| +41% | +$1.12M | 0.13% | 58 |
|
|
2017
Q4 | $3.25M | Buy |
181,500
+85,000
| +88% | +$1.77M | 0.2% | 56 |
|
|
2017
Q3 | $2.42M | Buy |
+96,500
| New | +$2.25M | 0.11% | 74 |
|
Water Island Capital's PRTK Position: Q3 2023 in Review
Water Island Capital sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 84,697 shares — an estimated $187K sold.
Water Island Capital first reported a position in PRTK in Q3 2017 and held it in 23 quarters. The position peaked at $4.26M in Q3 2018. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- Water Island Capital reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Water Island Capital sold 84,697 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $187K.
- Water Island Capital first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2017 and held it in 23 quarters.
- Water Island Capital's Paratek Pharmaceuticals, Inc. position peaked at $4.26M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on Water Island Capital's 13F filing for Q3 2023, filed 14 Nov 2023.